Key Takeaways HIMS has gained 111.4% over the past year, outperforming LFMD's 43.4% rise in the same period.HIMS is scaling via AI-driven care, hormone therapies, and international expansion efforts.LFMD boosts margins with in-house pharmacy, GLP-1 programs, and enterprise telehealth deals.Virtual healthcare platforms are redefining patient access to care, with Hims & Hers Health, Inc. (HIMS) and LifeMD, Inc. (LFMD) leading this digital shift. Hims & Hers delivers affordable, subscription-based treatments a ...